Seroepidemiological study of Herpes simplex virus 2 in human immuno deficiency virus-positive individuals attending a tertiary care hospital of South India

Manoj Kumar Singh, Krishna Santosh Halthur, Jithendra Kandati, Premanadam Narukuru, Siva Prasad Reddy Basava


Background: Herpes Simplex Virus-2 (HSV-2) infection is widely studied and associated disease in human immuno deficiency virus-positive (HIV-positive) individuals. The diagnosis of HSV is difficult as the presentations are atypical. Studies have confirmed that HSV-2 infection increases the risk of HIV acquisition by 2-3 folds. The aim of the study was to estimate the seroprevalence of HSV-2 and its association with age, sex and behavioral characters among HIV-infected individuals attending a tertiary care hospital.

Methods: Serum samples from 150 HIV positive patients were collected and screened for HSV-2 Ig G antibodies by indirect ELISA. The cut off index (COI) of each serum sample was determined by dividing the OD which was obtained for that serum sample, by the average OD of the cutoff serum. A COI below or equal to 1 was considered as negative and that above 1.1 was considered as positive.

Results: The overall seroprevalence of HSV-2 in the study was 44% (95% CI: 36-52%) with more in men than women. Out of 92 men, 42 (45.65%) were HSV positive and 24 (41.38%) of 58 female were positive. Statistical significance was observed in participants who had past history of sexually transmitted disease and who had multiple sexual partners (≥11) making as risk factors for HSV-2 seropositivity. Genital herpes was reported in 41 of 150 participants and seropositivity was 51.22% indicating the lack of awareness and most of the infections are asymptomatic.

Conclusions: Our study demonstrated a clear increase in seroprevalence of HSV-2 in HIV-infected individuals. Findings of our study have relevant public implications and strongly suggest the implementation of interventions in sexually transmitted infections to reduce the prevalence of HSV-2 and associated HIV transmission. As most of the infections of HSV are asymptomatic a continuous program for the screening of HSV in all cases of STD’s must be made to reduce the chances of acquisition of HIV and others. 


Seroprevalence, Herpes simplex virus-2, Human immuno deficiency virus, Sexually transmitted diseases

Full Text:



Bock P, Beyers N, Fidler S. Balancing the need to rapidly scale-up and improve clinical outcomes in antiretroviral programmes in developing countries: Lessons from an Indian programmatic cohort study. Trans R Soc Trop Med Hyg. 2014;108:599-600.

Galvin SR, Cohen MS. The role of sexually transmitted diseases in HIV transmission. Nat Rev Microbiol. 2004;2:33-42.

Siegal FP, Lopez C, Hammer GS. Severe acquired immunodeficiency in male homosexuals, manifested by chronic perianal ulcerative herpes simplex lesions. N Engl J Med 1981;305:1439-44.

Strick LB, Wald A, Celum C. Management of herpes simplex virus 2 infection in HIV type 1-infected persons. Clin Infect Dis. 2006;43:347-56.

Mcgrath BJ, Newman CL. Genital herpes simplex infections in patients with the acquired immunodeficiency syndrome. Pharmacotherapy. 1994;14:529-42.

Xu F, Sternberg MR, Gottlieb SL, Berman SM, Markowitz LE, Forhan SE, et al. Seroprevalence of herpes simplex virus type 2 among persons aged 14-49 years, United States, 2005-2008. MMWR Morb Mortal Wkly Rep. 2010;59(15):456-9.

Cunningham AL, Taylor R, Taylor J, Marks C, Shaw J, Mindel A. Prevalence of infection with herpes simplex virus types 1 and 2 in Australia: a nationwide population based survey. Sex Transm Infect. 2006;82(2):164-8.

Mawak JD, Dashe N, Atseye A, Agabi Y, Zakeri H. Seroprevalence and co-infection of herpes simplex virus type 2 and human immunodeficiency virus in Nigeria. Shiraz E-Med J. 2012;13(1):33-9.

Lin H, He N, Su M, Feng J, Chen L, Gao M. Herpes simplex virus infections among rural residents in eastern China. BMC Infect Dis. 2011;11:69.

Schneider JA, Lakshmi V, Dandona R, Kumar GA, Sudha T, Dandona L. Population-based seroprevalence of HSV-2 and syphilis in Andhra Pradesh state of India. BMC Infect Dis. 2010;10:59.

Sgaier SK, Mony P, Jayakumar S, Mclaughlin C, Arora P, Kumar R, et al. Prevalence and correlates of herpes simplex virus-2 and syphilis infections in the general population in India. Sex Transm Infect. 2011;87(2):94-100.

Sripriya M, Rajendran P, Seethalakshmi I, Karthikeyan M, Gnanasekaran AG, Kannan M, et al. Herpes simplex virus type 2 infection and associated risk factors among weaver’s community in Tamil Nadu state, India. Curr Res Microbiol Biotech. 2013;1(4):143-7.

Wald A, Link K. Risk of human immunodeficiency virus infection in herpes simplex virus type 2 seropositive persons: a meta-analysis. J Infect Dis.2002;198:45-52.

Rode OD, Lepej SZ, Begovac J. Seroprevalence of herpes simplex virus type 2 in adult HIV-infected patients and blood donors in Croatia. Coll Antropol. 2008;32(3):693-5.

Anuradha K, Singh HM, Gopal KVT, Rao GRR, Ramani TV, Padmaja J. Herpes simplex virus 2 infection: a risk factor for HIV infection in heterosexuals. Indian J Dermatol Venereol Leprol. 2008;74:230-3.

Venkateshwaran SP, Murugesan K, Sivaraj R. Seroprevalence of IgG and IgM antibodies in individuals with herpes simplex virus-1 and 2 infection in HIV positive and negative individuals of south Indian population. J Appl Pharm Sci. 2011;1(10):154-8.

HSV-2 treatment interventions to control HIV: hope for the future? Available at ftgu/article/view/2000/3996. Accessed on 23 April 2016.

Reyes M, Graber J, Reeves W. Acyclovir-resistant HSV: preliminary results from a national surveillance system. Paper presented at: International Conference on Emerging Infectious Diseases. 1998.

Chakraborty N, Bhattacharyya S, De C, Mukherjee A, Bhattacharya D, Santra S, et al. Incidence of multiple herpes virus infection in HIV seropositive patients, a big concern for eastern Indian scenario. Virol J. 2010;7:147-53.

Karad AB, Khade SL. Seroepidemiological study of herpes simplex virus type 2 infection in HIV positive patients, Delhi, India, 2007. Int J Med Public Health. 2013;3:168-72.

Schaftenaar E, Verjans GM, Getu S, McIntyre JA, Struthers HE, Osterhaus ADME, et al. High seroprevalence of human herpes viruses in HIV-infected patients attending primary healthcare facilities in rural South Africa. PLoS One. 2014;9(6):99243.

Nakubulwa S, Mirembe FM, Kaye DK, Kaddu-Mulindwa D. Association between HSV 2 and HIV serostatus in pregnant women of known HIV serostatus attending Mulago Hospital antenatal clinic, Kampala, Uganda. J Infect Dev Ctries. 2009;3(10):803-6.

Jacob SM, Gopal T, Kanagasabai S, Durairaj A, Sushi KM, Arumugam G. Herpes simplex virus 2 infection in HIV-seropositive individuals in Tamil Nadu, India. Int J Med Sci Public Health. 2015;4:404-7.

Nahmias A, Lee F, Beckman, Nahamias S. Seroepidemiological and sociological patterns of herpes simplex virus infection in the world. Scand J Infect Dis .1990;69:19-36.

Mertz GJ. Epidemiology of genital herpes infections. Infect Dis Clin North Am. 1993;7:825-39.

Santos OLR, Silva AG, Pereira AC. Herpes simples genital. Uma doença sexualmente transmissível. F Méd .1995;110:77-98.

Santos FC, Setubal S, Camacho LAB, Faillace T, Leite JPG, Velarde LJC. Seroepidemiological study of herpes simplex virus type 2 in patients with the acquired immunodeficiency syndrome in the City of Niterói, Rio de Janeiro, Brazil. Mem Inst Oswaldo Cruz, Rio de Janeiro. 2006;101(3):315-9.

Russel DB, Tabrizi SN, Russel JM, Garland SM. Seroprevalence of herpes simplex virus types 1 and 2 in HIV-infected and uninfected homosexual men in a primary care setting. J Clin Virol. 2001;22:305-13.

Van BHB, Spaargaren J, Van JAR, Merks J, Coutinho RA, Prins M, European Study on the natural history of HIV infection in women. Prevalence and risk factors of HSV-1 and HSV-2 antibodies in European HIV infected women. Sex Transm Infect. 2001;77:120-4.

Burrows J, Nitsche A, Bayly B, Walker E, Higgins G, Kok T. Detection and sub typing of herpes simplex virus in clinical samples by light cycler pcr, enzyme immunoassay and cell culture. British Med Microbiology. 2002;2:12.